Revance Therapeutics, Inc.
EIR issued July 2, 2021 · Newark, California
- Pages
- 6
- FEI number
- 3007772056
In short: This is FDA's Establishment Inspection Report (EIR) for Revance Therapeutics, Inc. in Newark, California (FEI 3007772056). It is the investigator's full narrative of what they examined, who they spoke to and what they found.
Inside this inspection report
The investigator's narrative
The full inspection report: what the investigator looked at, who they spoke to and what they found, in their own words.
Get the full EIRThis inspection in context
Questions about this EIR
When was Revance Therapeutics, Inc. inspected by FDA?
This EIR is dated July 2, 2021.
How do I get the full EIR for Revance Therapeutics, Inc.?
Download the original PDF from FDA Intel for $550, with no subscription. You also get an invoice PDF with the order.